Gayatri Premshekharan
Gayatri Premshekharan
Postdoctoral fellow, UCSF
Verified email at urology.ucsf.edu
Title
Cited by
Cited by
Year
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration‐resistant prostate cancer
TW Friedlander, VT Ngo, H Dong, G Premasekharan, V Weinberg, S Doty, ...
International journal of cancer 134 (10), 2284-2293, 2014
1072014
Looking back, to the future of circulating tumor cells
TW Friedlander, G Premasekharan, PL Paris
Pharmacology & therapeutics 142 (3), 271-280, 2014
872014
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
A Anantharaman, T Friedlander, D Lu, R Krupa, G Premasekharan, ...
BMC cancer 16 (1), 744, 2016
722016
Circulating tumor cells as potential biomarkers in bladder cancer
A Alva, T Friedlander, M Clark, T Huebner, S Daignault, M Hussain, C Lee, ...
The Journal of urology 194 (3), 790-798, 2015
662015
Iron-mediated lipid peroxidation and lipid raft disruption in low-dose silica-induced macrophage cytokine production
G Premasekharan, K Nguyen, J Contreras, V Ramon, VJ Leppert, ...
Free Radical Biology and Medicine 51 (6), 1184-1194, 2011
292011
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer
G Premasekharan, E Gilbert, RA Okimoto, A Hamirani, KJ Lindquist, ...
Cancer Letters 380 (1), 144-152, 2016
282016
High-dose abiraterone acetate in men with castration resistant prostate cancer
TW Friedlander, JN Graff, K Zejnullahu, A Anantharaman, L Zhang, R Paz, ...
Clinical Genitourinary Cancer 15 (6), 733-741. e1, 2017
112017
Real-time transferrin-based PET detects MYC-positive prostate cancer
R Aggarwal, SC Behr, PL Paris, C Truillet, MFL Parker, LT Huynh, J Wei, ...
Molecular Cancer Research 15 (9), 1221-1229, 2017
102017
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer
Y Su, Y Liu, CR Behrens, S Bidlingmaier, NK Lee, R Aggarwal, ...
JCI insight 3 (17), 2018
82018
Measurement of copy number variation in single cancer cells using rapid-emulsification digital droplet MDA
SC Kim, G Premasekharan, IC Clark, HB Gemeda, PL Paris, AR Abate
Microsystems & nanoengineering 3 (1), 1-7, 2017
62017
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients.
A Anantharaman, TW Friedlander, D Lu, R Krupa, G Premasekharan, ...
Journal of Clinical Oncology 34 (2_suppl), 446-446, 2016
32016
Initial results from a phase II study of increased-dose abiraterone acetate in patients with castration resistant prostate cancer (CRPC).
TW Friedlander, JN Graff, L Zhang, R Paz, G Premasekharan, A Dilip, ...
Journal of Clinical Oncology 33 (7_suppl), 188-188, 2015
12015
Abstract A153: Isolation and characterization of high-purity invasive CTCs from men with metastatic castration-resistant prostate cancer (mCRPC).
G Premasekharan, TW Friedlander, VT Ngo, E Gilbert, P Sathaye, ...
Molecular Cancer Therapeutics 12 (11 Supplement), A153-A153, 2013
12013
Abstract LB-327: Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies
L Szpankowski, G Premasekharan, N Ramalingam, C Sanada, A Leyrat, ...
Cancer Research 76 (14 Supplement), LB-327-LB-327, 2016
2016
Isolation and mRNA-seq analysis of single CTCs from blood samples using an integrated fluidic circuit for functional single cell studies
L Szpankowski, G Premasekharan, N Ramalingam, C Sanada, A Leyrat, ...
CANCER RESEARCH 76, 2016
2016
ERASE: Elimination of recurring artifacts and stochastic errors: An NGS analysis approach and its application to liquid biopsy samples.
N Kamps-Hughes, T Tran, R Brobey, RJ Amato, AS Alva, P Paris, ...
Journal of Clinical Oncology 34 (15_suppl), e13002-e13002, 2016
2016
Programmed death-ligand 1 characterization of circulating tumor cells and white blood cells in muscle-invasive and metastatic bladder cancer patients.
TW Friedlander, D Lu, R Krupa, G Premasekharan, CJ Welty, R Paz, ...
Journal of Clinical Oncology 33 (7_suppl), 353-353, 2015
2015
Abstract IA20: Molecular and genomic characterization of invasive circulating tumorcells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC)
TW Friedlander, G Premasekharan, A Dilip, J Tawney, V Ngo, E Gilbert, ...
Clinical Cancer Research 21 (4 Supplement), IA20-IA20, 2015
2015
Molecular and genomic characterization of invasive circulating tumor cells (iCTCs) from men with metastatic castration-resistant prostate cancer (mCRPC).
TW Friedlander, G Premasekharan, V Ngo, E Hang, JN Graff, CJ Ryan, ...
Journal of Clinical Oncology 32 (15_suppl), 11013-11013, 2014
2014
Isolation and characterization of high-purity invasive CTCs from men with metastatic castration-resistant prostate cancer (mCRPC).
G Premasekharan, TW Friedlander, VT Ngo, E Gilbert, P Sathaye, ...
MOLECULAR CANCER THERAPEUTICS 12 (11), 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–20